Jan Niederdoeckl

发表

The Impact of the COVID-19 Pandemic on Incidences of Atrial Fibrillation and Electrical Cardioversion at a Tertiary Care Emergency Department: An Inter- and Intra-year Analysis

A. Laggner, A. Spiel, H. Domanovits, 2020, Frontiers in Medicine.

Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.

A. Laggner, H. Herkner, A. Spiel, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Cardioversion of Post-Ablation Atrial Tachyarrhythmia with Ibutilide and Amiodarone: A Registry-Based Cohort Study

A. Laggner, H. Herkner, A. Spiel, 2022, International journal of environmental research and public health.

Association of Intravenous Potassium and Magnesium Administration With Spontaneous Conversion of Atrial Fibrillation and Atrial Flutter in the Emergency Department

A. Laggner, H. Herkner, A. Spiel, 2022, JAMA network open.

Body Weight Counts—Cardioversion with Vernakalant or Ibutilide at the Emergency Department

A. Spiel, H. Domanovits, S. Schnaubelt, 2022, Journal of clinical medicine.

Vernakalant and electrical cardioversion for AF – Safe and effective

A. Laggner, H. Herkner, A. Spiel, 2019, International journal of cardiology. Heart & vasculature.

Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department

Hyperkalemia: A persisting risk. A case report and update on current management

M. Hecking, A. Spiel, C. Schoergenhofer, 2020, Clinical case reports.

Expert Opinion: Meditation and Cardiovascular Health: What is the Link?

Lorenz Koller, Alexander Niessner, L. Koller, 2019, European cardiology.